Anticoccidial Drugs Market
Anticoccidial Drugs Market Size, Share & Trends Analysis Report, By Drug Class (Ionophores, Chemical Anticoccidials), By Animal Type (Poultry, Livestock, Companion Animals), By End-User (Commercial Poultry Farms, Livestock Farms, Veterinary Clinics & Hospitals, Pet Owners), Forecast Period (2026-2035)
Industry Overview
Anticoccidial drugs market size was valued at $1.90 billion in 2025 and is projected to reach $2.91 billion by 2035, growing at a CAGR of 4.35% between 2026 and 2035. The market includes pharmaceutical products used to prevent and treat coccidiosis, a parasitic disease affecting poultry, livestock, and companion animals. These drugs are essential for maintaining animal health, improving feed efficiency, and minimizing production losses in intensive farming systems. A key factor driving market growth is the rising global demand for animal protein. According to the Food and Agriculture Organization, global poultry production has witnessed consistent growth due to increasing consumption of affordable protein sources. Additionally, expanding livestock farming and commercial poultry operations are increasing the need for preventive healthcare solutions. Growing awareness regarding animal disease management, along with increasing investments in veterinary healthcare, is further supporting market expansion. The adoption of medicated feed additives and advanced veterinary treatments is strengthening the demand for anticoccidial drugs across major end-use industries such as poultry farming, livestock production, and veterinary services.
Market Dynamics
Increasing Livestock Production Driving Market Growth
The rapid expansion of livestock and poultry farming is a major factor driving the anticoccidial drugs market. These drugs are widely used to control coccidiosis, which significantly affects productivity and animal health. According to the Organisation for Economic Co-operation and Development, global meat demand is expected to grow steadily, supporting increased livestock production worldwide. Large-scale farming practices have increased the risk of disease outbreaks, making preventive treatments essential. Anticoccidial drugs are commonly incorporated into feed to ensure continuous protection and improved growth performance. Between 2023 and 2026, companies are focusing on developing combination therapies and advanced formulations to improve effectiveness and reduce resistance. Increasing adoption of integrated animal health management practices is further strengthening market demand.
Drug Resistance and Regulatory Constraints Limiting Growth
Despite strong demand, the anticoccidial drugs market faces challenges related to drug resistance and regulatory restrictions. Continuous usage of anticoccidial products has led to reduced effectiveness in certain cases, requiring the development of new treatment strategies. Regulatory authorities are also imposing strict guidelines on drug usage in animal feed to ensure food safety and limit chemical residues. Additionally, the growing demand for organic and antibiotic-free animal products is restricting the use of some chemical anticoccidials. Rising costs associated with drug development and compliance further impact market growth. To address these challenges, manufacturers are investing in alternative solutions such as vaccines, natural additives, and improved drug formulations. These innovations are expected to enhance long-term sustainability in the market.
Market Segmentation
- Based on the drug Class, the market is segmented into Ionophores and Chemical Anticoccidials.
- Based on the animal type, the market is segmented into poultry, livestock, and companion animals.
- Based on the end-user, the market is segmented into commercial poultry farms, livestock farms, veterinary clinics & hospitals, and pet owners.
Poultry Segment Leads the Market
The poultry segment holds a dominant position in the anticoccidial drugs market due to the high incidence of coccidiosis in poultry production systems. Intensive farming environments create conditions that facilitate parasite transmission, increasing the need for preventive treatments. Anticoccidial drugs are widely used in poultry feed to improve feed conversion efficiency and reduce mortality rates. Increasing demand for poultry meat and eggs between 2022 and 2026 is further supporting segment growth. Manufacturers are focusing on developing targeted drug formulations and improving resistance management strategies to enhance performance in poultry farming.
Companion Animals Segment to Record Strong Growth
The companion animals’ segment is expected to witness strong growth due to rising pet ownership and increasing awareness regarding animal health. Pet owners are increasingly investing in preventive healthcare and veterinary treatments, including antiparasitic solutions. Advancements in veterinary pharmaceuticals and the availability of specialized treatment options are supporting this segment. Increasing urbanization and the growing trend of pet humanization are further driving demand. Companies are focusing on expanding their companion animal product portfolios to capture this growing market opportunity.
Regional Outlook
The global anticoccidial drugs market is geographically segmented into North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa and Latin America).
United States Leads the Market
The United States dominates the anticoccidial drugs market due to its advanced livestock farming practices and strong veterinary healthcare infrastructure. According to the U.S. Department of Agriculture, the country is a leading producer of poultry and livestock products globally.
High adoption of preventive healthcare solutions and continuous investments in animal health technologies are supporting market growth. Additionally, the presence of major pharmaceutical companies and ongoing research activities contribute to innovation in anticoccidial drug development.
India to Record Strong Growth
India is expected to witness strong growth due to rapid expansion of poultry and livestock industries. According to the Food and Agriculture Organization, India is one of the largest producers of milk and poultry products globally.
Increasing demand for protein-rich diets, along with government initiatives to improve livestock productivity, is driving market growth. Rising investments in veterinary healthcare infrastructure and growing awareness regarding disease prevention are further supporting the adoption of anticoccidial drugs in the country.
Competitive Landscape
The anticoccidial drugs market is highly competitive, characterized by strong focus on product innovation and expansion strategies. Leading companies such as Elanco Animal Health, Zoetis Inc., Huvepharma, Phibro Animal Health Corporation, and Ceva Santé Animale are focusing on strengthening their product portfolios and expanding global presence.
Recent Developments
- In April 2026, Elanco Animal Health Incorporated launched the Advantage™ Collar for Dogs, offering up to four months of continuous protection against fleas, ticks, and mosquitoes. The product utilizes a time-release formula with Pyriproxyfen to break the flea lifecycle and prevent reinfestation, enhancing long-term parasite control. This launch strengthens Elanco’s over-the-counter pet healthcare portfolio and expands its Advantage brand family, while providing an affordable and convenient solution for pet owners. The product’s wide retail availability supports increased market penetration and reinforces Elanco’s position in the companion animal parasiticide segment.
- In March 2026, Zoetis Inc. announced the acquisition of Neogen Corporation’s animal genomics business for $160 million to strengthen its Precision Animal Health portfolio. This strategic move enables Zoetis to integrate advanced genomic technologies, enhancing predictive insights, genetic testing capabilities, and individualized animal care. The acquisition expands Zoetis’ global footprint across more than 120 countries and supports livestock producers with data-driven decision-making tools, improving productivity, sustainability, and overall animal health outcomes.
The Report Covers
- Market value data analysis of 2025 and forecast to 2035.
- Annualised market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global anticoccidial drugs market. Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Global Anticoccidial Drugs Market Sales Analysis – Drug Class | Animal Type | End-User ($ Million)
- Anticoccidial Drugs Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
2.1 Scope of the Study
2.2 Analyst Insight & Current Market Trends
2.2.1 Key Anticoccidial Drugs Market Trends
2.2.2 Market Recommendations
2.3 Porter’s Five Forces Analysis for the Anticoccidial Drugs Market
2.3.1 Competitive Rivalry
2.3.2 Threat of New Entrants
2.3.3 Bargaining Power of Suppliers
2.3.4 Bargaining Power of Buyers
2.3.5 Threat of Substitutes
- Market Determinants
3.1 Market Drivers
3.1.1 Drivers For Global Anticoccidial Drugs Market: Impact Analysis
3.2 Market Pain Points and Challenges
3.2.1 Restraints For Global Anticoccidial Drugs Market: Impact Analysis
3.3 Market Opportunities
3.3.1 Opportunities For Global Anticoccidial Drugs Market: Impact Analysis
- Competitive Landscape
4.1 Competitive Dashboard – Anticoccidial Drugs Market Revenue and Share by Manufacturers
- Anticoccidial Drugs Product Comparison Analysis
- Top Market Player Ranking Matrix
4.2 Key Company Analysis
4.2.1 Elanco Animal Health
4.2.1.1 Overview
4.2.1.2 Product Portfolio
4.2.1.3 Financial Analysis
4.2.1.4 SWOT Analysis
4.2.1.5 Business Strategy
4.2.2 Zoetis Inc.
4.2.2.1 Overview
4.2.2.2 Product Portfolio
4.2.2.3 Financial Analysis
4.2.2.4 SWOT Analysis
4.2.2.5 Business Strategy
4.2.3 Huvepharma
4.2.3.1 Overview
4.2.3.2 Product Portfolio
4.2.3.3 Financial Analysis
4.2.3.4 SWOT Analysis
4.2.3.5 Business Strategy
4.2.4 Phibro Animal Health Corporation??
4.2.4.1 Overview
4.2.4.2 Product Portfolio
4.2.4.3 Financial Analysis
4.2.4.4 SWOT Analysis
4.2.4.5 Business Strategy
4.2.5 Ceva Santé Animale
4.2.5.1 Overview
4.2.5.2 Product Portfolio
4.2.5.3 Financial Analysis
4.2.5.4 SWOT Analysis
4.2.5.5 Business Strategy
4.3 Top Winning Strategies by Market Players
4.3.1 Merger and Acquisition
4.3.2 Product Launch
4.3.3 Partnership And Collaboration
- Global Anticoccidial Drugs Market Sales Analysis by Drug Class ($ Million)
5.1 Ionophores
5.2 Chemical Anticoccidials
- Global Anticoccidial Drugs Market Sales Analysis by Animal Type ($ Million)
6.1 Poultry
6.2 Livestock
6.3 Companion Animals
- Global Anticoccidial Drugs Market Sales Analysis by End-User ($ Million)
7.1 Commercial Poultry Farms
7.2 Livestock Farms
7.3 Veterinary Clinics & Hospitals
7.4 Pet Owners (Companion segment)
- Regional Analysis
8.1 North American Anticoccidial Drugs Market Sales Analysis – Drug Class | Animal Type | End-User ($ Million)
8.1.1 United States
8.1.2 Canada
8.2 European Anticoccidial Drugs Market Sales Analysis – Drug Class | Animal Type | End-User ($ Million)
8.2.1 UK
8.2.2 Germany
8.2.3 Italy
8.2.4 Spain
8.2.5 France
8.2.6 Russia
8.2.7 Rest of Europe
8.3 Asia-Pacific Anticoccidial Drugs Market Sales Analysis – Drug Class | Animal Type | End-User ($ Million)
8.3.1 China
8.3.2 Japan
8.3.3 South Korea
8.3.4 India
8.3.5 Australia & New Zealand
8.3.6 ASEAN Countries
8.3.7 Rest of Asia-Pacific
8.4 Rest of the World Anticoccidial Drugs Market Sales Analysis – Drug Class | Animal Type | End-User ($ Million)
8.4.1 Latin America
8.4.2 Middle East and Africa
- Company Profiles
9.1 Aurobindo Pharma
9.1.1 Quick Facts
9.1.2 Company Overview
9.1.3 Product Portfolio
9.1.4 Business Strategies
9.2 Bimeda Corporate
9.2.1 Quick Facts
9.2.2 Company Overview
9.2.3 Product Portfolio
9.2.4 Business Strategies
9.3 Bioproperties Pty Ltd
9.3.1 Quick Facts
9.3.2 Company Overview
9.3.3 Product Portfolio
9.3.4 Business Strategies
9.4 Boehringer Ingelheim Animal Health
9.4.1 Quick Facts
9.4.2 Company Overview
9.4.3 Product Portfolio
9.4.4 Business Strategies
9.5 Cargill, Inc.
9.5.1 Quick Facts
9.5.2 Company Overview
9.5.3 Product Portfolio
9.5.4 Business Strategies
9.6 Dopharma B.V.
9.6.1 Quick Facts
9.6.2 Company Overview
9.6.3 Product Portfolio
9.6.4 Business Strategies
9.7 Hebei Veyong Pharmaceutical Co., Ltd.
9.7.1 Quick Facts
9.7.2 Company Overview
9.7.3 Product Portfolio
9.7.4 Business Strategies
9.8 Hipra, S.A.
9.8.1 Quick Facts
9.8.2 Company Overview
9.8.3 Product Portfolio
9.8.4 Business Strategies
9.9 Impextraco NV
9.9.1 Quick Facts
9.9.2 Company Overview
9.9.3 Product Portfolio
9.9.4 Business Strategies
9.10 Intas Pharmaceuticals Ltd.
9.10.1 Quick Facts
9.10.2 Company Overview
9.10.3 Product Portfolio
9.10.4 Business Strategies
9.11 Kela Health
9.11.1 Quick Facts
9.11.2 Company Overview
9.11.3 Product Portfolio
9.11.4 Business Strategies
9.12 Kemin Industries, Inc.
9.12.1 Quick Facts
9.12.2 Company Overview
9.12.3 Product Portfolio
9.12.4 Business Strategies
9.13 Lallemand Animal Nutrition
9.13.1 Quick Facts
9.13.2 Company Overview
9.13.3 Product Portfolio
9.13.4 Business Strategies
9.14 LIVISTO Group
9.14.1 Quick Facts
9.14.2 Company Overview
9.14.3 Product Portfolio
9.14.4 Business Strategies
9.15 Merck Animal Health
9.15.1 Quick Facts
9.15.2 Company Overview
9.15.3 Product Portfolio
9.15.4 Business Strategies
9.16 Norbrook Laboratories
9.16.1 Quick Facts
9.16.2 Company Overview
9.16.3 Product Portfolio
9.16.4 Business Strategies
9.17 Venky's (India) Limited
9.17.1 Quick Facts
9.17.2 Company Overview
9.17.3 Product Portfolio
9.17.4 Business Strategies
9.18 Vetoquinol S.A.
9.18.1 Quick Facts
9.18.2 Company Overview
9.18.3 Product Portfolio
9.18.4 Business Strategies
9.19 Virbac
9.19.1 Quick Facts
9.19.2 Company Overview
9.19.3 Product Portfolio
9.19.4 Business Strategies
9.20 Zydus Lifesciences
9.20.1 Quick Facts
9.20.2 Company Overview
9.20.3 Product Portfolio
9.20.4 Business Strategies
1. Global Anticoccidial Drugs Market Research and Analysis by Drug Class, 2025–2035 ($ Million)
2. Global Ionophores Anticoccidial Drugs Market Research and Analysis by Region, 2025–2035 ($ Million)
3. Global Chemical Anticoccidials Anticoccidial Drugs Market Research and Analysis by Region, 2025–2035 ($ Million)
4. Global Anticoccidial Drugs Market Research and Analysis by Animal Type, 2025–2035 ($ Million)
5. Global Poultry Anticoccidial Drugs Market Research and Analysis by Region, 2025–2035 ($ Million)
6. Global Livestock Anticoccidial Drugs Market Research and Analysis by Region, 2025–2035 ($ Million)
7. Global Companion Animals Anticoccidial Drugs Market Research and Analysis by Region, 2025–2035 ($ Million)
8. Global Anticoccidial Drugs Market Research and Analysis by End-User, 2025–2035 ($ Million)
9. Global Anticoccidial Drugs for Commercial Poultry Farms Research and Analysis by Region, 2025–2035 ($ Million)
10. Global Anticoccidial Drugs for Livestock Farms Research and Analysis by Region, 2025–2035 ($ Million)
11. Global Anticoccidial Drugs for Veterinary Clinics & Hospitals Research and Analysis by Region, 2025–2035 ($ Million)
12. Global Anticoccidial Drugs for Pet Owners (Companion segment) Research and Analysis by Region, 2025–2035 ($ Million)
13. Global Anticoccidial Drugs Market Research and Analysis by Region, 2025–2035 ($ Million)
14. North America Anticoccidial Drugs Market Research and Analysis by Country, 2025–2035 ($ Million)
15. North America Anticoccidial Drugs Market Research and Analysis by Drug Class, 2025–2035 ($ Million)
16. North America Anticoccidial Drugs Market Research and Analysis by Animal Type, 2025–2035 ($ Million)
17. North America Anticoccidial Drugs Market Research and Analysis by End-User, 2025–2035 ($ Million)
18. Europe Anticoccidial Drugs Market Research and Analysis by Country, 2025–2035 ($ Million)
19. Europe Anticoccidial Drugs Market Research and Analysis by Drug Class, 2025–2035 ($ Million)
20. Europe Anticoccidial Drugs Market Research and Analysis by Animal Type, 2025–2035 ($ Million)
21. Europe Anticoccidial Drugs Market Research and Analysis by End-User, 2025–2035 ($ Million)
22. Asia-Pacific Anticoccidial Drugs Market Research and Analysis by Country, 2025–2035 ($ Million)
23. Asia-Pacific Anticoccidial Drugs Market Research and Analysis by Drug Class, 2025–2035 ($ Million)
24. Asia-Pacific Anticoccidial Drugs Market Research and Analysis by Animal Type, 2025–2035 ($ Million)
25. Asia-Pacific Anticoccidial Drugs Market Research and Analysis by End-User, 2025–2035 ($ Million)
26. Rest of the World Anticoccidial Drugs Market Research and Analysis by Region, 2025–2035 ($ Million)
27. Rest of the World Anticoccidial Drugs Market Research and Analysis by Drug Class, 2025–2035 ($ Million)
28. Rest of the World Anticoccidial Drugs Market Research and Analysis by Animal Type, 2025–2035 ($ Million)
29. Rest of the World Anticoccidial Drugs Market Research and Analysis by End-User, 2025–2035 ($ Million)
1. Global Anticoccidial Drugs Market Share by Drug Class, 2025 Vs 2035 (%)
2. Global Ionophores Anticoccidial Drugs Market Share by Region, 2025 Vs 2035 (%)
3. Global Chemical Anticoccidials Anticoccidial Drugs Market Share by Region, 2025 Vs 2035 (%)
4. Global Anticoccidial Drugs Market Share by Animal Type, 2025 Vs 2035 (%)
5. Global Poultry Anticoccidial Drugs Market Share by Region, 2025 Vs 2035 (%)
6. Global Livestock Anticoccidial Drugs Market Share by Region, 2025 Vs 2035 (%)
7. Global Companion Animals Anticoccidial Drugs Market Share by Region, 2025 Vs 2035 (%)
8. Global Anticoccidial Drugs Market Share by End-User, 2025 Vs 2035 (%)
9. Global Anticoccidial Drugs for Commercial Poultry Farms Market Share by Region, 2025 Vs 2035 (%)
10. Global Anticoccidial Drugs for Livestock Farms Market Share by Region, 2025 Vs 2035 (%)
11. Global Anticoccidial Drugs for Veterinary Clinics & Hospitals Market Share by Region, 2025 Vs 2035 (%)
12. Global Anticoccidial Drugs for Pet Owners (Companion segment) Market Share by Region, 2025 Vs 2035 (%)
13. Global Anticoccidial Drugs Market Share by Region, 2025 Vs 2035 (%)
14. US Anticoccidial Drugs Market Size, 2025–2035 ($ Million)
15. Canada Anticoccidial Drugs Market Size, 2025–2035 ($ Million)
16. UK Anticoccidial Drugs Market Size, 2025–2035 ($ Million)
17. France Anticoccidial Drugs Market Size, 2025–2035 ($ Million)
18. Germany Anticoccidial Drugs Market Size, 2025–2035 ($ Million)
19. Italy Anticoccidial Drugs Market Size, 2025–2035 ($ Million)
20. Spain Anticoccidial Drugs Market Size, 2025–2035 ($ Million)
21. Russia Anticoccidial Drugs Market Size, 2025–2035 ($ Million)
22. India Anticoccidial Drugs Market Size, 2025–2035 ($ Million)
23. China Anticoccidial Drugs Market Size, 2025–2035 ($ Million)
24. Japan Anticoccidial Drugs Market Size, 2025–2035 ($ Million)
25. South Korea Anticoccidial Drugs Market Size, 2025–2035 ($ Million)
26. Australia & New Zealand Anticoccidial Drugs Market Size, 2025–2035 ($ Million)
27. ASEAN Anticoccidial Drugs Market Size, 2025–2035 ($ Million)
28. Rest of Asia-Pacific Anticoccidial Drugs Market Size, 2025–2035 ($ Million)
29. Latin America Anticoccidial Drugs Market Size, 2025–2035 ($ Million)
30. Middle East & Africa Anticoccidial Drugs Market Size, 2025–2035 ($ Million)
- Printable version
- No restriction to number of users within the company
